Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,192 | 15,112 | 11,782 | 43,497 | 21,352 |
| Receivables | 2,347 | 1,028 | 2,402 | 0 | 1,001 |
| Other current assets | 0 | 0 | 586 | 0 | 0 |
| TOTAL | $22,023 | $17,127 | $16,619 | $45,982 | $24,411 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 10,097 | 3,571 |
| Other Non-Current Assets | 0 | 0 | 17,803 | 12,056 | 17,633 |
| TOTAL | $N/A | $N/A | $17,803 | $22,153 | $21,204 |
| Total Assets | $22,023 | $17,127 | $34,422 | $68,135 | $45,615 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,465 | 3,075 | 2,521 | 11,135 | 6,013 |
| TOTAL | $3,465 | $3,075 | $7,782 | $12,902 | $6,402 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 1,146 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 7,039 | 11,248 | 11,868 |
| TOTAL | $N/A | $N/A | $7,039 | $11,248 | $11,868 |
| Total Liabilities | $3,465 | $3,075 | $14,821 | $24,150 | $18,270 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,709 | 8,903 | 8,799 | 8,308 | 5,073 |
| Common Shares | 11 | 9 | 8 | 8 | 51 |
| Retained earnings | -447,017 | -436,286 | -428,049 | -398,118 | -356,240 |
| TOTAL | $18,558 | $14,053 | $19,601 | $43,986 | $27,345 |
| Total Liabilities And Equity | $22,023 | $17,127 | $34,422 | $68,135 | $45,615 |